Table 1.
Baseline characteristics stratified by sex and randomized regimen.
Table 2.
Number of participants that discontinued regimens or missed quality of life assessment.
Fig 1.
Mean EQ-5D utility (Quality of life) score by PrEP study regimen over time.
Legend: Mean utility measured by EQ-5D, converted to health utility using U.S. valuation weights, where 0 is equivalent to death and 1 to perfect health. MVC = maraviroc, TDF = tenofovir disoproxil fumarate, FTC = emtricitabine.
Table 3.
Mean EQ-5D utility (Quality of life) score at week 48 by continuation of study regimen.
Fig 2.
Mean EQ-5D visual analogue scale (VAS) score by PrEP study regimen over time.
Mean utility measured by EQ-5D VAS, where 0 is the worst health the respondent can imagine, and 100 is the best. MVC = maraviroc, TDF = tenofovir disoproxil fumarate, FTC = emtricitabine.